{"id":"corticosteroid-or-nsaid","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal bleeding or ulceration (NSAIDs)"},{"rate":null,"effect":"Immunosuppression and infection risk (corticosteroids)"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Osteoporosis (chronic corticosteroid use)"},{"rate":null,"effect":"Cardiovascular events (NSAIDs)"}]},"_chembl":{"chemblId":"CHEMBL5970128","moleculeType":null,"molecularWeight":"607.73"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This entry represents two distinct drug classes with different mechanisms. Corticosteroids work systemically to dampen immune cell activation and cytokine production. NSAIDs act peripherally to block COX-1 and COX-2 enzymes, reducing inflammatory mediators and pain signaling. Both are used to manage inflammatory and autoimmune conditions, though through different pathways.","oneSentence":"Corticosteroids suppress immune and inflammatory responses by binding glucocorticoid receptors, while NSAIDs inhibit cyclooxygenase enzymes to reduce prostaglandin production and inflammation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:31:16.619Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune disorders (corticosteroids)"},{"name":"Pain and inflammation management (NSAIDs)"}]},"trialDetails":[{"nctId":"NCT05292339","phase":"PHASE4","title":"Ketorolac in Upper Extremity Tendinopathy and Arthropathy","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-01-31","conditions":"Osteoarthritis, Tendinopathy, Arthropathy","enrollment":160},{"nctId":"NCT06643845","phase":"NA","title":"Can Multimodal Medical Strategies Can Delay Total Knee Replacement?","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-09","conditions":"Osteoarthritis, Knee","enrollment":1000},{"nctId":"NCT06594822","phase":"PHASE3","title":"Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2023-08-24","conditions":"Rheumatoid Arthritis","enrollment":88},{"nctId":"NCT04485325","phase":"PHASE4","title":"Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients","status":"COMPLETED","sponsor":"Dr. Frank Behrens","startDate":"2019-11-04","conditions":"Rheumatic Arthritis","enrollment":92},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06498440","phase":"PHASE4","title":"Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT","status":"NOT_YET_RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2024-09-01","conditions":"Open Angle Glaucoma, Ocular Hypertension, Postoperative Inflammation","enrollment":126},{"nctId":"NCT03301883","phase":"PHASE4","title":"A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2018-04-26","conditions":"Juvenile Idiopathic Arthritis","enrollment":62},{"nctId":"NCT05941130","phase":"PHASE4","title":"3D Evaluation of Postoperative Edema After Third Molar Surgery","status":"UNKNOWN","sponsor":"Implantology Institute","startDate":"2022-07-01","conditions":"Molar, Third, Third Molar Surgery, Soft Tissue Swelling","enrollment":40},{"nctId":"NCT01939691","phase":"PHASE4","title":"Macular Edema Nepafenac vs. Difluprednate Uveitis Trial","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2018-09-12","conditions":"Uveitis, Macular Edema","enrollment":9},{"nctId":"NCT02266433","phase":"PHASE3","title":"Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2012-08","conditions":"DeQuervains Tenosynovitis, Lateral Epicondylitis, Tennis Elbow","enrollment":245},{"nctId":"NCT02717871","phase":"PHASE3","title":"Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2016-03","conditions":"Keratitis; Infectious Disease (Manifestation)","enrollment":35},{"nctId":"NCT03319784","phase":"PHASE4","title":"Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2018-09-05","conditions":"Rotator Cuff Tear, Rotator Cuff Injury, Rotator Cuff Tendinitis","enrollment":""},{"nctId":"NCT03104985","phase":"NA","title":"LLLT of Trophic Ulcers of Lower Extremities and Chronic Venous Insufficiency","status":"COMPLETED","sponsor":"Research Center Matrix","startDate":"2013-05","conditions":"Trophic Ulcers, Chronic Venous Insufficiency","enrollment":68},{"nctId":"NCT03616340","phase":"PHASE3","title":"Efficacy of Intra-articular NSAID Versus Corticosteroid in the Treatment of Shoulder and Knee Conditions: A Randomized, Double-Blind, Prospective Study","status":"UNKNOWN","sponsor":"OSF Healthcare System","startDate":"2018-08","conditions":"Knee Arthritis, Shoulder Arthritis, Shoulder Impingement","enrollment":50},{"nctId":"NCT01196091","phase":"PHASE3","title":"A Study of LY2127399 in Participants With Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2010-12","conditions":"Systemic Lupus Erythematosus, Connective Tissue Disease, Autoimmune Disease","enrollment":1164},{"nctId":"NCT00443651","phase":"PHASE3","title":"A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2007-01","conditions":"Rheumatoid Arthritis","enrollment":578},{"nctId":"NCT01058278","phase":"NA","title":"Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2008-03","conditions":"Glaucoma, Inflammatory Response","enrollment":67},{"nctId":"NCT02613455","phase":"PHASE4","title":"Corticosteroid Injection Verses High Energy Extracorporeal Shock Wave Therapy for Lateral Epicondylitis","status":"UNKNOWN","sponsor":"Walter Reed National Military Medical Center","startDate":"2015-07","conditions":"Lateral Epicondylitis, Tennis Elbow","enrollment":80},{"nctId":"NCT00691171","phase":"","title":"Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-01","conditions":"GERD","enrollment":5234},{"nctId":"NCT00462345","phase":"PHASE4","title":"A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2007-06","conditions":"Rheumatoid Arthritis","enrollment":40},{"nctId":"NCT01442428","phase":"PHASE2, PHASE3","title":"Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2014-01","conditions":"Immune Reconstitution Inflammatory Syndrome, Immune Reconstitution Syndrome, Tuberculosis","enrollment":""},{"nctId":"NCT00707421","phase":"PHASE3","title":"Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2005-07","conditions":"Glaucoma, Trabeculectomy, Fibrosis","enrollment":62}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":424211,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Corticosteroid or NSAID","genericName":"Corticosteroid or NSAID","companyName":"Hoffmann-La Roche","companyId":"roche","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Corticosteroids suppress immune and inflammatory responses by binding glucocorticoid receptors, while NSAIDs inhibit cyclooxygenase enzymes to reduce prostaglandin production and inflammation. Used for Inflammatory and autoimmune disorders (corticosteroids), Pain and inflammation management (NSAIDs).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}